Elgodipine - CAS 119413-55-7

Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun. The Elgodipine-induced inhibition was voltage-dependent. Elgodipine is a potential compound for the treatment of angina pectoris.

Others, Calcium Channel

Metabolism, Others, Membrane transporter/Ion channel

119351

0.9998

C29H33FN2O6

524.58

C(OCCN(CC1=CC=C(F)C=C1)C)(=O)C=2C(C(C(OC(C)C)=O)=C(C)NC2C)C3=C4C(=CC=C3)OCO4

-20°C

Ice Packs

Small Compound